WeVote
Log In

Bill

SK

Bill

HB 6550

AN ACT CONCERNING VACCINE AVAILABILITY AND AFFORDABILITY.

2025 Regular Session Introduced by Sarah Keitt

Connecticut HB 6550 proposes measures to improve vaccine access and reduce costs for state residents through policy modifications under legislative review.

REF. TO JOINT COMM. ON Public Health
#immunization
0
WeVote Research Nonpartisan
Bill Summary · HB 6550

Legislative bill overview

HB 6550 addresses vaccine availability and affordability in Connecticut, though specific provisions are not detailed in the information provided. The bill was introduced by Representative Sarah Keitt and referred to the Joint Committee on Public Health on January 24, 2025 for review and consideration.

Why is this important

Vaccine access and cost are significant public health policy issues affecting immunization rates and disease prevention outcomes. Legislation in this area can influence healthcare equity, insurance coverage requirements, and the state's ability to maintain community immunity against preventable diseases.

Potential points of contention

  • Cost-sharing mechanisms: Disagreement over whether vaccines should be fully covered, cost-shared, or have out-of-pocket expenses, affecting different socioeconomic groups differently
  • Insurance mandate scope: Debate over which vaccines should be mandated coverage, whether to include newer vaccines, and how to balance comprehensive protection with insurance costs
  • Public funding allocation: Concerns about state budget implications and whether public funds should subsidize vaccines for specific populations versus universal coverage approaches

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.